Lab Results Of Passengers Returning From Moscow, Minsk, Kuwait, Douala, Bahrain, Dubai, London And U

Lab Results of Passengers Returning From Moscow, Minsk, Kuwait, Douala, Bahrain, Dubai, London and Ukraine

The Ministry of Public Health announces the following results of the tests performed for the passengers on board the flights to Lebanon as part of the second phase of Lebanese repatriation:

Ten confirmed COVID-19 cases among the Lebanese on board the plane from Moscow.
One confirmed COVID-19 case among the returnees from Minsk.
One infection on board the flight from Kuwait. Two passengers on board the same plane will be retested.
Two positive cases among the passengers returning from Douala.
No positive cases among the passengers returning from Bahrain, Dubai, London and Ukraine; all the tests came back negative.

The passengers whose test results returned positive will be transferred to the hospital. Those who tested negative are urged to strictly comply with home-quarantine, and they will be daily followed up by the ministry. Any person who shows symptoms will be sent to the hospital and retested.

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L04AX04	LENOMA	G	Lenalidomide - 25mg	25mg	Capsule, hard	L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g, Lidocaine (ampoule) -	0.5g	Injectable powder for solution+diluent	403,153 L.L
N03AX14	LEPITAM	G	Levetiracetam - 100mg/ml	100mg/ml	Solution	1,336,163 L.L
L04AX04	LENOMA	G	Lenalidomide - 15mg	15mg	Capsule, hard	L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g, Lidocaine (ampoule) -	0.5g	Injectable powder for solution+diluent	403,153 L.L
N03AX14	LEVETIRACETAM ARROW	G	Levetiracetam - 100mg/ml	100mg/ml	Solution	1,639,488 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution	3,455,595 L.L
N03AX14	LEVETRIMED	G	Levetiracetam - 100mg/ml	100mg/ml	Solution	1,336,163 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution+diluent	511,940 L.L
N03AX14	LEVIPRAM	G	Levetiracetam - 100mg/ml	100mg/ml	Solution	1,285,609 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution+diluent	511,940 L.L
N03AX14	LEVIPRAM IV	G	Levetiracetam - 500mg/100ml	500mg/100ml	Injectable solution	1,869,733 L.L
N03AX14	LEVIPRAM IV	G	Levetiracetam - 1000mg/100ml	1000mg/100ml	Injectable solution	2,911,659 L.L
L04AA27	LYXIA	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule, hard	32,406,715 L.L
C10BA05	LIPONORM PLUS 10/10	G	Atorvastatin - 10mg, Ezetimibe - 10mg		Tablet	974,286 L.L
N03AX18	LACOSAMIDE/GENEPHARM	G	Lacosamide - 50mg	50mg	Tablet	614,136 L.L
L04AA27	LYXIA	G	Fingolimod Hydrochloride - 0.25mg	0.5mg	Capsule, hard	32,406,715 L.L
N03AX18	LACOSAMIDE/GENEPHARM	G	Lacosamide - 100mg	100mg	Tablet	4,856,647 L.L
R06AX13	LORADAD	G	Loratadine - 10mg	10mg	Tablet	131,697 L.L
C10BA05	LIPONORM PLUS 20/10	G	Atorvastatin - 20mg, Ezetimibe - 10mg		Tablet	1,226,928 L.L
R06AX13	LORATIN	G	Loratadine (micronised) - 10mg	10mg	Tablet	247,267 L.L
R06AX13	LORINE	G	Loratadine (micronised) - 10mg	10mg	Tablet	247,267 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution+diluent	643,765 L.L
N03AX18	LACOSAMIDE/GENEPHARM	G	Lacosamide - 200mg	200mg	Tablet	8,284,105 L.L
D11AX18	LABDIC RELIEF	G	Diclofenac sodium - 1%w/w, Methyl salicylate - 8%w/w, Menthol - 2%w/w		Gel	263,393 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 1g, Lidocaine (ampoule) -	1g	Injectable powder for solution+diluent	568,253 L.L
R06AX13	LORINE	G	Loratadine (micronised) - 5mg/5ml	5mg/5ml	Syrup	215,015 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution	5,793,881 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution+diluent	508,100 L.L
J01DD04	LEBACEF	G	Ceftriaxone - 1g	1g	Injectable sterile powder for solution + lidocaine solvent	508,100 L.L

...